What question did this study set out to answer?

This research aims to discover genes related to cuproptosis and mitophagy for better myocardial infarction diagnosis and treatment.

March 3, 2026

Discovery of Genes Related to Cuproptosis and Mitophagy to Improve Myocardial Infarction Diagnosis and Treatment

Key Result

GPCPD1, S100A8, and CD55 are core genes linked to cuproptosis that serve as potential diagnostic markers and therapeutic targets for myocardial infarction.

Key Points

This research aims to discover genes related to cuproptosis and mitophagy for better myocardial infarction diagnosis and treatment.
Identified core genes through genomic analysis.
Evaluated potential as diagnostic markers.
Investigated functional roles in copper-dependent cell death.
Core genes GPCPD1, S100A8, and CD55 identified as potential diagnostic markers.
These genes play functional roles in the copper-dependent cell death pathway.
Improved understanding of mechanisms can enhance myocardial infarction treatment.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

The core genes (GPCPD1, S100A8, and CD55) identified in this study not only served as potential diagnostic markers but were also functional nodes in copper-dependent cell death, contributing to MI treatment.

Bookmark

Cite This Study

Xue et al. (Thu,) reported a other. GPCPD1, S100A8, and CD55 are core genes linked to cuproptosis that serve as potential diagnostic markers and therapeutic targets for myocardial infarction.

synapsesocial.com/papers/69a67ed1f353c071a6f0a5bc https://doi.org/https://doi.org/10.2174/0115665232440699251209120654